Search details
1.
Antioxidant defense enzymes in multiple sclerosis: A 5-year follow-up study.
Eur J Neurol
; 30(8): 2338-2347, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37151181
2.
Temperature stability of urinary F2-isoprostane and 8-hydroxy-2'-deoxyguanosine.
Pract Lab Med
; 39: e00373, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38420043
3.
Exploratory 5-year follow-up study of retinol, tocopherols, and carotenoids in multiple sclerosis.
Mult Scler Relat Disord
; 81: 105143, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38039941
4.
Therapeutic efficacy of the humanized JAA-F11 anti-Thomsen-Friedenreich antibody constructs H2aL2a and H3L3 in human breast and lung cancer xenograft models.
Oncotarget
; 13: 1155-1164, 2022 10 19.
Article
in English
| MEDLINE | ID: mdl-36264086
5.
Preclinical Analysis of JAA-F11, a Specific Anti-Thomsen-Friedenreich Antibody via Immunohistochemistry and In Vivo Imaging.
Transl Oncol
; 11(2): 450-466, 2018 Apr.
Article
in English
| MEDLINE | ID: mdl-29477636
6.
Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and InVitro Efficacy Analysis.
Neoplasia
; 19(9): 716-733, 2017 Sep.
Article
in English
| MEDLINE | ID: mdl-28830009
7.
Corrigendum to "Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and In Vitro Efficacy Analysis" [Neoplasia 19.9 (2017) 716-733].
Neoplasia
; 20(1): 118, 2018 01.
Article
in English
| MEDLINE | ID: mdl-29277397
Results
1 -
7
de 7
1
Next >
>>